Amethis has made a significant minority investment in Spanish cosmetics company HB Aesthetics to support its international expansion and growth.
Target Information
Amethis Europe Expansion has made a significant minority investment in HB Aesthetics, a European player in the cosmetics industry, through a primary leveraged buyout (LBO). This investment was made alongside the company’s president and founder, Raphaël Chauchard-Rios. Established in 2014, HB Aesthetics specializes in designing and distributing high-end dermocosmetic products primarily targeted at professional customers like dermatologists, clinics, beauty institutes, and spas.
Located in Vilafant, at the heart of Spain's cosmetic valley, HB Aesthetics boasts a robust internal R&D structure, manufacturing capabilities, and a training center. The company offers products under two main brands: Fusion Meso, which features a complete range of sterile serums for use with various devices (including micro-needling and ultrasounds), sold exclusively to aesthetic professionals; and Ekseption, focusing on products based on natural organic acids aimed at restoring the skin's natural pH.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The cosmetics industry in Spain has experienced significant growth, driven by innovation and consumer demand for quality products. With a robust manufacturing base and a focus on R&D, Spain has become a prominent player in the European
Similar Deals
PHI Industrial → Panalia Derivados de la Harina and Palinox Ingeniería y Proyectos
2025
Amethis Europe Expansion
invested in
HB Aesthetics
in 2023
in a Buyout deal